Analysis of Reportable Segments
Allergan Inc. operates in 2 segments: Specialty pharmaceuticals and Medical devices.
Segment Profit Margin
Allergan Inc., profit margin by reportable segment
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Specialty pharmaceuticals | 47.11% | 42.74% | 41.75% | 39.79% | 37.80% |
| Medical devices | 34.37% | 28.68% | 30.17% | 31.25% | 33.64% |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
Segment Profit Margin: Specialty pharmaceuticals
Allergan Inc.; Specialty pharmaceuticals; segment profit margin calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income | 2,832,300) | 2,282,000) | 1,997,700) | 1,763,300) | 1,501,900) |
| Product net sales | 6,012,100) | 5,339,000) | 4,784,600) | 4,432,000) | 3,973,400) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 47.11% | 42.74% | 41.75% | 39.79% | 37.80% |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Segment profit margin = 100 × Operating income ÷ Product net sales
= 100 × 2,832,300 ÷ 6,012,100 = 47.11%
Segment Profit Margin: Medical devices
Allergan Inc.; Medical devices; segment profit margin calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income | 382,900) | 246,200) | 278,800) | 286,000) | 284,700) |
| Product net sales | 1,114,000) | 858,500) | 924,200) | 915,100) | 846,200) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 34.37% | 28.68% | 30.17% | 31.25% | 33.64% |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Segment profit margin = 100 × Operating income ÷ Product net sales
= 100 × 382,900 ÷ 1,114,000 = 34.37%
Product net sales
Allergan Inc., product net sales by reportable segment
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Specialty pharmaceuticals | 6,012,100) | 5,339,000) | 4,784,600) | 4,432,000) | 3,973,400) |
| Medical devices | 1,114,000) | 858,500) | 924,200) | 915,100) | 846,200) |
| Total | 7,126,100) | 6,197,500) | 5,708,800) | 5,347,100) | 4,819,600) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
Operating income
Allergan Inc., operating income by reportable segment
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Specialty pharmaceuticals | 2,832,300) | 2,282,000) | 1,997,700) | 1,763,300) | 1,501,900) |
| Medical devices | 382,900) | 246,200) | 278,800) | 286,000) | 284,700) |
| Total | 3,215,200) | 2,528,200) | 2,276,500) | 2,049,300) | 1,786,600) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).